Global Heart Pump Device Market Size, Share, and Industry Analysis – by Device Type, by Procedure, and by End-use – Growth and Trend Forecast, 2026 -2035

The global heart pump device market was estimated to be worth USD 3,324.97 million in 2025. The market is expected to expand at a compound annual growth rate (CAGR) of 13.8% throughout the forecast period. The growing incidence of heart failure, the increasing adoption of mechanical circulatory support devices, and improvements in cardiac care technologies are driving the market.

Published: March 25, 2026
100 Pages

Market Overview

The American Heart Association estimates that 6.7 million adult Americans suffered from heart failure in 2022, which increased the need for sophisticated heart pump equipment.

The heart pump device market has experienced steady growth over the past decade due to improvements in mechanical circulatory support technologies, the growing use of ventricular assist devices (VADs), and the transition from large, pulsatile pumps to compact, continuous-flow devices, which have improved patient outcomes and increased clinical utilization. For instance, Abbott Laboratories reported better results with its HeartMate 3 LVAD in 2022, encouraging further use of advanced heart pump devices.

The heart pump device market is anticipated to develop significantly during the forecast period due to the growing emphasis on long-term cardiac support solutions and rising demand for destination therapy and bridge-to-transplant options. For instance, Medtronic is anticipated to develop next-generation implantable heart pump devices with enhanced remote monitoring capabilities by 2030, enabling better patient management and long-term cardiac care.

Heart Pump Device Market Overview

Base Year Market Size (2025): USD 3,324.97 Million

CAGR: 13.8%

Forecast Year Market Size (2035): USD 28.3 Billion

Leading Region: North America

Emerging Countries: India, Brazil, China, South Africa and South Korea

Major Players:

  • Abbott Laboratories

  • Johnson & Johnson (Abiomed)

  • Medtronic

  • Terumo Corporation

  • LivaNova

Heart Pump Device Market Trends

The heart pump device market is evolving rapidly due to growing clinical uses and improvements in mechanical circulatory support technologies.

· The growing use of ventricular assist devices (VADs) as destination therapy and a bridge to transplant is a significant trend that extends their use beyond short-term assistance.

· There is a growing shift toward implantable and compact heart pump devices, providing enhanced patient movement, reduced size, and increased durability.

· The development of extracorporeal and next-generation ECMO systems is enhancing short-term cardiac support for critically ill patients.

· Additionally, growing attention on long-term heart support options is promoting the transition from transient devices to long-term mechanical circulatory support treatments.

Collectively, these developments are driving the market toward more sophisticated, long-lasting, and patient-focused heart pump technologies, fostering sustained expansion and broader clinical acceptance.

Heart Pump Device Market Analysis

By Device Type

Ventricular assist devices (VADs) provide effective mechanical circulatory support by improving cardiac output in patients with severe heart failure.

Based on device type, the heart pump device market is segmented into ventricular assist devices (VADs), total artificial heart, and temporary mechanical circulatory support devices. The ventricular assist devices (VADs) segment accounted for the largest revenue share of 69.32% in 2025.

By Procedure Type

High-risk PCI enables effective cardiac support during complex coronary interventions, improving procedural safety and outcomes in critical patients.

Based on procedure type, the heart pump device market is segmented into bridge to transplant (BTT), destination therapy, bridge to recovery, high-risk percutaneous coronary intervention (PCI), cardiogenic shock management, ventricular tachycardia (VT) ablation, and high-risk valvuloplasty. The high-risk PCI segment accounted for the largest revenue share in 2025.

By End-use

Hospitals offer sophisticated cardiac care facilities and special expertise for handling intricate heart pump device treatments

Based on end-use, the heart pump device market is categorized into hospitals, cardiology centers, and others. The hospitals segment dominated the market with the largest revenue share in 2025.

Regional Analysis

North America gains from early adoption of cutting-edge heart pump technologies and sophisticated cardiac care systems.

North America dominated the heart pump device market with the largest revenue share of 50.22% in 2025.

Europe is witnessing steady progress with rising adoption of advanced heart pump technologies and evolving cardiac care practices.

Rising rates of cardiovascular illness, better access to sophisticated cardiac care, and more use of mechanical circulatory support devices are all expected to contribute to Europe's significant growth over the course of the forecast period.

Key Companies Profiled

The heart pump device market is characterized by intense competition between long-standing firms and emerging innovators. Leading corporations, including as Abbott Laboratories, Johnson & Johnson (Abiomed), Medtronic, Terumo Corporation, and LivaNova, maintain a substantial market share due to modern VAD technologies and ongoing innovation. For instance, Johnson & Johnson strengthened its position in minimally invasive cardiac pump solutions in 2023 by expanding its Impella device portfolio.

Heart Pump Device Market Companies:

  • Abbott Laboratories

  • Abiomed (Johnson & Johnson)

  • Berlin Heart

  • BiVACOR Inc.

  • Getinge AB

  • Jarvik Heart, Inc.

  • Leviticus Cardio

  • LivaNova PLC

  • Medtronic plc

  • SynCardia Systems, LLC

  • Teleflex Incorporated

  • Terumo Corporation

Market Segmentation

This study provides revenue growth and emerging trends across global, regional, and country levels from 2021 to 2035, segmenting the heart pump device market by-

  • Device Type (Revenue in USD Million, 2021 - 2035)

    • Ventricular Assist Devices (VADs)

      • Left Ventricular Assist Devices (LVADs)

      • Right Ventricular Assist Devices (RVADs)

      • BiVAD Ventricular Assist Devices (BiVADs)

    • Total Artificial Heart (TAH)

    • Temporary Mechanical Circulatory Support Devices

      • Percutaneous Ventricular Assist Devices (PVADs)

      • Intra-Aortic Balloon Pumps (IABPs)

      • Extracorporeal Membrane Oxygenation (ECMO)

  • Procedure Type (Revenue in USD Million, 2021 - 2035)

    • Bridge to Transplant (BTT)

    • Destination Therapy

    • Bridge to Recovery

    • High-Risk Percutaneous Coronary Intervention (PCI)

    • Cardiogenic Shock Management:

    • Ventricular Tachycardia (VT) Ablation

    • High-risk Valvuloplasty

  • End-use (Revenue in USD Million, 2021 – 2035)

    • Hospitals

    • Cardiology Centers

    • Others

  • Regional (Revenue in USD Million, 2021 - 2035)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Spain

      • Denmark

      • Sweden

      • Norway

      • Switzerland

      • Netherlands

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • Thailand

      • South Korea

      • Indonesia

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Colombia

    • Middle East and Africa

      • South Africa

      • Saudi Arabia

      • UAE

      • Kuwait

Table of Content

1. Methodology and Scope

1.1. Scope of the Study

1.1.1. Market Segmentation

1.1.2. Market Definition

1.1.3. Inclusions and Exclusions of the Study

1.2. Research Design

1.2.1. Base Year, Historical Data, and Forecast Period

1.2.2. Data Collection Methods

1.2.2.1. Secondary Sources

1.2.2.2. Primary Sources

1.2.3. Research Methodology

1.2.3.1. Base Year Calculation/ Parent Market Analysis, Company/ Brand Share Analysis, 2025 (Top-down Approach)

1.2.3.2. Volume-Price Approach (Bottom-up Approach)

1.2.3.3. Data Triangulation

1.2.4. Forecasting Model

1.3. Research Assumptions

1.4. Validation and Data Quality Control

1.5. List of Primary Sources

1.6. List of Secondary Sources

2. Executive Summary

2.1. Market Overview

2.2. Segment Snapshot

2.3. Competitive Landscape Snapshot

3. Industry Outlook

3.1. Industry Ecosystem Analysis

3.2. Parent/ Ancillary Market Analysis

3.3. Market Dynamics

3.3.1. Drivers

3.3.2. Restraints/ Challenges

3.3.3. Opportunities

3.4. Consumer Behaviour Analysis

3.5. Value Chain Analysis

3.6. Technology Roadmap

3.7. Porters Analysis

3.8. PESTLE Analysis

4. Market Estimates and Forecasts, By Device Type, 2021 - 2035 (Market Size in USD Mn)

4.1. Ventricular Assist Devices (VADs)

4.1.1. Left Ventricular Assist Devices (LVADs)

4.1.2. Right Ventricular Assist Devices (RVADs)

4.1.3. BiVAD Ventricular Assist Devices (BiVADs)

4.2. Total Artificial Heart (TAH)

4.3. Temporary Mechanical Circulatory Support Devices

4.3.1. Percutaneous Ventricular Assist Devices (PVADs)

4.3.2. Intra-Aortic Balloon Pumps (IABPs)

4.3.3. Extracorporeal Membrane Oxygenation (ECMO)

5. Market Estimates and Forecasts, By Procedure Type, 2021 – 2035 (USD Mn)

5.1. Bridge to Transplant (BTT)

5.2. Destination Therapy

5.3. Bridge to Recovery

5.4. High-Risk Percutaneous Coronary Intervention (PCI)

5.5. Cardiogenic Shock Management:

5.6. Ventricular Tachycardia (VT) Ablation

5.7. High-risk Valvuloplasty

6. Market Estimates and Forecasts, By End-use, 2021 – 2035 (USD Mn)

6.1. Hospitals

6.2. Cardiology Centers

6.3. Others

7. Market Estimates and Forecasts, By Region, 2021 - 2035 (USD Mn)

7.1. North America

7.1.1. U.S.

7.1.1.1. U.S. Heart Pump Device Market Estimates and Forecasts to 2035 (USD Mn)

7.1.1.2. Market Dynamics

7.1.1.3. Competitive Landscape

7.1.1.4. Regulatory Framework

7.1.1.5. Reimbursement Scenario

7.1.2. Canada

7.1.2.1. Canada Heart Pump Device Market Estimates and Forecasts to 2035 (USD Mn)

7.1.2.2. Market Dynamics

7.1.2.3. Competitive Landscape

7.1.2.4. Regulatory Framework

7.1.2.5. Reimbursement Scenario

7.2. Europe

7.2.1. Germany

7.2.1.1. Germany Heart Pump Device Market Estimates and Forecasts to 2035 (USD Mn)

7.2.1.2. Market Dynamics

7.2.1.3. Competitive Landscape

7.2.1.4. Regulatory Framework

7.2.1.5. Reimbursement Scenario

7.2.2.

7.2.3. U.K.

7.2.3.1. UK Heart Pump Device Market Estimates and Forecasts to 2035 (USD Mn)

7.2.3.2. Market Dynamics

7.2.3.3. Competitive Landscape

7.2.3.4. Regulatory Framework

7.2.3.5. Reimbursement Scenario

7.2.4. France

7.2.4.1. France Heart Pump Device Market Estimates and Forecasts to 2035 (USD Mn)

7.2.4.2. Market Dynamics

7.2.4.3. Competitive Landscape

7.2.4.4. Regulatory Framework

7.2.4.5. Reimbursement Scenario

7.2.5. Italy

7.2.5.1. Italy Heart Pump Device Market Estimates and Forecasts to 2035 (USD Mn)

7.2.5.2. Market Dynamics

7.2.5.3. Competitive Landscape

7.2.5.4. Regulatory Framework

7.2.5.5. Reimbursement Scenario

7.2.6. Spain

7.2.6.1. Spain Heart Pump Device Market Estimates and Forecasts to 2035 (USD Mn)

7.2.6.2. Market Dynamics

7.2.6.3. Competitive Landscape

7.2.6.4. Regulatory Framework

7.2.6.5. Reimbursement Scenario

7.2.7. Sweden

7.2.7.1. Sweden Heart Pump Device Market Estimates and Forecasts to 2035 (USD Mn)

7.2.7.2. Market Dynamics

7.2.7.3. Competitive Landscape

7.2.7.4. Regulatory Framework

7.2.7.5. Reimbursement Scenario

7.2.8. Norway

7.2.8.1. Norway Heart Pump Device Market Estimates and Forecasts to 2035 (USD Mn)

7.2.8.2. Market Dynamics

7.2.8.3. Competitive Landscape

7.2.8.4. Regulatory Framework

7.2.8.5. Reimbursement Scenario

7.2.9. Denmark

7.2.9.1. Denmark Heart Pump Device Market Estimates and Forecasts to 2035 (USD Mn)

7.2.9.2. Market Dynamics

7.2.9.3. Competitive Landscape

7.2.9.4. Regulatory Framework

7.2.9.5. Reimbursement Scenario

7.2.10. Switzerland

7.2.10.1. Switzerland Heart Pump Device Market Estimates and Forecasts to 2035 (USD Mn)

7.2.10.2. Market Dynamics

7.2.10.3. Competitive Landscape

7.2.10.4. Regulatory Framework

7.2.10.5. Reimbursement Scenario

7.2.11. Netherlands

7.2.11.1. Netherlands Heart Pump Device Market Estimates and Forecasts to 2035 (USD Mn)

7.2.11.2. Market Dynamics

7.2.11.3. Competitive Landscape

7.2.11.4. Regulatory Framework

7.2.11.5. Reimbursement Scenario

7.2.12. Rest of Europe

7.2.12.1. Rest of Europe Heart Pump Device Market Estimates and Forecasts to 2035 (USD Mn)

7.2.12.2. Market Dynamics

7.2.12.3. Competitive Landscape

7.2.12.4. Regulatory Framework

7.2.12.5. Reimbursement Scenario

7.3. Asia Pacific

7.3.1. China

7.3.1.1. China Heart Pump Device Market Estimates and Forecasts to 2035 (USD Mn)

7.3.1.2. Market Dynamics

7.3.1.3. Competitive Landscape

7.3.1.4. Regulatory Framework

7.3.1.5. Reimbursement Scenario

7.3.2. Japan

7.3.2.1. Japan Heart Pump Device Market Estimates and Forecasts to 2035 (USD Mn)

7.3.2.2. Market Dynamics

7.3.2.3. Competitive Landscape

7.3.2.4. Regulatory Framework

7.3.2.5. Reimbursement Scenario

7.3.3. India

7.3.3.1. India Heart Pump Device Market Estimates and Forecasts to 2035 (USD Mn)

7.3.3.2. Market Dynamics

7.3.3.3. Competitive Landscape

7.3.3.4. Regulatory Framework

7.3.3.5. Reimbursement Scenario

7.3.4. Australia

7.3.4.1. Australia Heart Pump Device Market Estimates and Forecasts to 2035 (USD Mn)

7.3.4.2. Market Dynamics

7.3.4.3. Competitive Landscape

7.3.4.4. Regulatory Framework

7.3.4.5. Reimbursement Scenario

7.3.5. South Korea

7.3.5.1. South Korea Heart Pump Device Market Estimates and Forecasts to 2035 (USD Mn)

7.3.5.2. Market Dynamics

7.3.5.3. Competitive Landscape

7.3.5.4. Regulatory Framework

7.3.5.5. Reimbursement Scenario

7.3.6. Thailand

7.3.6.1. Thailand Heart Pump Device Market Estimates and Forecasts to 2035 (USD Mn)

7.3.6.2. Market Dynamics

7.3.6.3. Competitive Landscape

7.3.6.4. Regulatory Framework

7.3.6.5. Reimbursement Scenario

7.3.7. Indonesia

7.3.7.1. Indonesia Heart Pump Device Market Estimates and Forecasts to 2035 (USD Mn)

7.3.7.2. Market Dynamics

7.3.7.3. Competitive Landscape

7.3.7.4. Regulatory Framework

7.3.7.5. Reimbursement Scenario

7.3.8. Rest of Asia Pacific

7.3.8.1. Rest of Asia Pacific Heart Pump Device Market Estimates and Forecasts to 2035 (USD Mn)

7.3.8.2. Market Dynamics

7.3.8.3. Competitive Landscape

7.3.8.4. Regulatory Framework

7.3.8.5. Reimbursement Scenario

7.4. Latin America

7.4.1. Brazil

7.4.1.1. Brazil Heart Pump Device Market Estimates and Forecasts to 2035 (USD Mn)

7.4.1.2. Market Dynamics

7.4.1.3. Competitive Landscape

7.4.1.4. Regulatory Framework

7.4.1.5. Reimbursement Scenario

7.4.2. Mexico

7.4.2.1. Mexico Heart Pump Device Market Estimates and Forecasts to 2035 (USD Mn)

7.4.2.2. Market Dynamics

7.4.2.3. Competitive Landscape

7.4.2.4. Regulatory Framework

7.4.2.5. Reimbursement Scenario

7.4.3. Argentina

7.4.3.1. Argentina Heart Pump Device Market Estimates and Forecasts to 2035 (USD Mn)

7.4.3.2. Market Dynamics

7.4.3.3. Competitive Landscape

7.4.3.4. Regulatory Framework

7.4.3.5. Reimbursement Scenario

7.4.4. Colombia

7.4.4.1. Colombia Heart Pump Device Market Estimates and Forecasts to 2035 (USD Mn)

7.4.4.2. Market Dynamics

7.4.4.3. Competitive Landscape

7.4.4.4. Regulatory Framework

7.4.4.5. Reimbursement Scenario

7.5. Middle East and Africa

7.5.1. South Africa

7.5.1.1. South Africa Heart Pump Device Market Estimates and Forecasts to 2035 (USD Mn)

7.5.1.2. Market Dynamics

7.5.1.3. Competitive Landscape

7.5.1.4. Regulatory Framework

7.5.1.5. Reimbursement Scenario

7.5.2. Saudi Arabia

7.5.2.1. Saudi Arabia Heart Pump Device Market Estimates and Forecasts to 2035 (USD Mn)

7.5.2.2. Market Dynamics

7.5.2.3. Competitive Landscape

7.5.2.4. Regulatory Framework

7.5.2.5. Reimbursement Scenario

7.5.3. UAE

7.5.3.1. UAE Heart Pump Device Market Estimates and Forecasts to 2035 (USD Mn)

7.5.3.2. Market Dynamics

7.5.3.3. Competitive Landscape

7.5.3.4. Regulatory Framework

7.5.3.5. Reimbursement Scenario

7.5.4. Kuwait

7.5.4.1. Kuwait Heart Pump Device Market Estimates and Forecasts to 2035 (USD Mn)

7.5.4.2. Market Dynamics

7.5.4.3. Competitive Landscape

7.5.4.4. Regulatory Framework

7.5.4.5. Reimbursement Scenario

7.5.5. Rest of Middle East and Africa

7.5.5.1. Rest of MEA Heart Pump Device Market Estimates and Forecasts to 2035 (USD Mn)

7.5.5.2. Market Dynamics

7.5.5.3. Competitive Landscape

7.5.5.4. Regulatory Framework

7.5.5.5. Reimbursement Scenario

8. Competitive Landscape

8.1. Company Market Share Analysis, 2024

8.2. Company Tier Structure

8.3. List of Major Suppliers, By Key Countries

8.4. Key Company Positioning Analysis

8.5. Company Profile

8.5.1. Abbott Laboratories

8.5.2. Abiomed (Johnson & Johnson)

8.5.3. Berlin Heart

8.5.4. BiVACOR Inc.

8.5.5. Getinge AB

8.5.6. Jarvik Heart, Inc.

8.5.7. Leviticus Cardio

8.5.8. LivaNova PLC

8.5.9. Medtronic plc

8.5.10. SynCardia Systems, LLC

8.5.11. Teleflex Incorporated

8.5.12. Terumo Corporation

8.6. Key Development Strategies

8.6.1. New Product Launches

8.6.2. Mergers and Acquisition

8.6.3. Partnerships and Collaborations

8.6.4. Expansion Plans

9. Analyst Perspective

10. Related Reports

Related Research

Global Hyaluronic Acid-Based Dermal Fillers Market Size, Share, and Industry Analysis- by Product Type, by Gender, by Elasticity Module, by Application, and by End-use, Growth and Trend Forecast, 2026 – 2035

April 23, 2026View

Global Non-invasive Fat Reduction Market Size, Share, and Industry Forecast – by Product Type, by Application, by Gender, and by End-use- Growth and Forecast, 2026- 2035

April 23, 2026View

Global Wound Care Market Size, Share, and Industry Analysis – by Product Type, by Wound Type, and by End-use – Growth and Trend Forecast, 2026 -2035

April 22, 2026View

Revolution Insights Briefs

Stay informed with updates on related market reports and key industry topics.